USFDA inspects Alembic Pharma's facility in Karkhadi, Gujarat
USFDA issued a form 483 with two observations, the drug firm said in a filing to BSE.
ICICI Bank introduces cardless cash withdrawal facility through ATMs
The service can be used for self-withdrawal when customers do not wish t...
Strides arm receives EIR for its US facility
The facility is one of the very few manufacturing facilities in the US with a soft gel capsule (...
Cipla announces closure of USFDA inspection at Patalganga facility
Cipla recently announced the closure of inspection by United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility in Maharashtra. Shares of Cipla were trading 0.40 per cent lower at Rs 478.35 apiece on the BSE in the morning trade.
Medium scale companies may be given credit risk cover
The Credit Guarantee Fund Trust for Micro and Small Enterprises, run by the government and financial institution Sidbi, has floated a consultation paper to banks, where it has estimated that it will get business of around Rs 4,000 crore during the first year.
Bank fraud: ED attaches over Rs 107 crore assets of Kolkata firm
Assets worth over Rs 107 crore of a Kolkata-based firm have been attached in connection with a money laundering probe linked to an alleged bank fraud case, the ED said on Tuesday.
Letter from Wall Street: Dear PM Modi, your politics can wait, but the economy cannot
Nothing is more important than dealing with the unfolding slowdown of the Indian economy.
Time to celebrate businesses that have enhanced stakeholder value
Let the numbers do the talking: Family-run businesses have generated 14% annual average share price return since 2006, compared with 6% for non-family firms in India, as per Credit Suisse’s Family 1000 in 2018 report.
Brokerages upbeat on RIL’s retail, telecom businesses, retain ratings
Of the 26 brokerage reports ET studied, eight have increased the price targets on RIL shares while six reduced it after the earnings. Nineteen of the 26 brokerages have a ‘buy’ rating on the stock, with the average price target given at over Rs 1,700.
Lupin gets 5 observations from USFDA for its Vizag facility
The inspection of company's Vizag API manufacturing facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in a filing to BSE. The inspection was carried out between January 13, 2020 and January 17, 2020, it added. The inspection for the API facility at Vizag closed with five 483 observations, Lupin said.
Flipkart’s ex-CTO allies with entrepreneur Raj Vattikuti to start credit firm
The duo has seeded the venture, DAVINTA, with Rs 140 crore of personal money. It already holds an NBFC licence, with disbursed loans of Rs 50 crore.
Global investors ready with $3 billion kitty to enter India’s credit market
Many global investors are looking for the first time to deploy $3 billion into India’s credit market, especially the structured credit segment.
Ujjivan SFB eyes small businesses amid retreat by NBFCs
Many Indian lenders are focusing their efforts on the lucrative retail loans’ business.
Noida girl fights for Rs 1.5 lakh stolen sans OTP or PIN
The three fraudulent transactions -- two on her HDFC debit card worth Rs 52,499.99 and Rs 44,544.24 and one on HDFC credit card worth Rs 52,499.99 were done at the same merchant called ASHANTI, PARIS 10/FR, on New Year's Eve.
Rising inequality eroding trust in capitalism: Survey
Rising income inequality is undermining confidence in capitalism around the world, according to a survey conducted by public relations firm Edelman ahead of the gathering of the elites in the Swiss ski resort of Davos.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service